Danish weight-loss giant Novo Nordisk has lost a US patent to generics manufacturer Viatris. A federal district court in Delaw...
Following Eli Lilly's disappointing earnings showing last week, Novo Nordisk’s latest report on the performance of its GLP-1 sta...